VEGF-related protein isolated from Vipera palestinae venom, promotes angiogenesis

Growth Factors

Volumn 25, Issue 2, 2007, Pages 108-117

  Brown, Meghan C ^a   Calvete, Juan J ^b   Staniszewska, Izabela ^a   Walsh, Erin M ^a   Perez Liz, Georgina ^a   Del Valle, Luis ^a   Lazarovici, Philip ^c   Marcinkiewicz, Cezary ^a  

^a TEMPLE UNIVERSITY   (United States)

^b INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Angiogenesis; Endothelial cells; Growth factors; VEGF

Indexed keywords

ANGIOGENESIS MODULATOR; MITOGEN ACTIVATED PROTEIN KINASE; SNAKE VENOM; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN F1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CELL ASSAY; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DRUG PURIFICATION; DRUG RECEPTOR BINDING; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL TRANSDUCTION; SNAKE; VIPERA PALESTINAE;

AMINO ACID SEQUENCE; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CHEMOTAXIS; COLLAGEN; COTURNIX; DRUG COMBINATIONS; ENDOTHELIAL CELLS; FEMALE; LAMININ; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VENOMS; VIPERIDAE;

COTURNIX JAPONICA; MAMMALIA; MUS; PHASIANIDAE; VIPERA;

EID: 34748869603     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190701532385     Document Type: Article

References (32)

1. Annex, BH and Simons, M. (2005) Growth factor-induced therapeutic angiogenesis in the heart: Protein therapy. Cardiovasc Res, 65, pp. 649-655.
2. Calvete, JJ, Moreno-Murciano, MP, Theakston, RDG, Kisiel, DG and Marcinkiewicz, C. (2003) Snake venom disintegrins: Novel dimeric disintegrins and structural diversification by disulphide bond engineering. Biochem J, 372, pp. 725-734.
3. Cao, Y., Hong, A., Schulten, H. and Post, MJ (2005) Update on therapeutic neovascularization. Cardiovasc Res, 65, pp. 639-648.
4. Carmeliet, P. (2003) Angiogenesis in health and disease. Nat Med, 9, pp. 653-660.
5. Chen, YL, Tsai, IH, Hong, TM and Tsai, SH (2005) Crotalid venom vascular endothelial growth factors has preferential affinity for VEGFR-1. Characterization of Protobothrops mucrosquamatus venom VEGF. Thromb Haemost, 93, pp. 331-338.
6. Ferrara, N. and Henzel, WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun, 161, pp. 851-858.
7. Folkman, J. (2005) Angiogenesis. Annu Rev Med, 57, pp. 1-18.
8. Fuh, G., Crowley, C., Cunnibgham, B. and Wells, JA (1998) Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. J Biol Chem, 273, pp. 11197-11204.
9. Gille, H., Kowalski, J., LeCouter, J., Moffat, B., Zioncheck, TF, Pelletier, N. and Ferrara, N. (2001) Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem, 276, pp. 3222-3230.
10. Gluzman-Poltorak, Z., Cohen, T., Herzog, Y. and Neufeld, G. (2000) Neuropilin-2 is a receptor for the vascular endothelail growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem, 275, pp. 18040-18045.
11. Gsami, A., Bourcier, C., Aloui, Z., Srairi, N., Marchetti, S., Gimond, S., Wedge, SR, Hennequin, L. and Pouyssegur, J. (2002) Complete structure of an increasing capillary permeability protein (ICPP) purified from Vipera lebetina venom. J Biol Chem, 277, pp. 29992-29998.
12. Juárez, P., Sanz, L. and Calvete, JJ (2004) Snake venomics: Characterization of protein families in Sistrurus barbouri venom by cysteine mapping, N-terminal sequencing, and tandem mass spectrometry analysis. Proteomics, 4, pp. 327-338.
13. Kisiel, DG, Calvete, JJ, Katzhendler, J., Fertala, A., Lazarovici, P. and Marcinkiewicz, C. (2004) Structural determinants of the selectivity of KTS-disintegrins for the a1b1 integrin. FEBS Lett, 577, pp. 465-469.
14. Komori, Y., Nikai, T., Taniguchi, T., Masuda, K. and Sugihara, H. (1999) Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper). Biochemistry, 38, pp. 11796-11803.
15. Lee, J., Gray, A., Yuan, J., Luoh, SM, Avraham, H. and Wood, WI (1996) Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA, 93, pp. 1988-1992.
16. Leung, DW, Cachiane, G., Kuang, WJ, Goddel, DV and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, pp. 1306-1309.
17. Maeshima, Y., Manfredi, M., Reimer, C., Holthaus, KA, Hopfer, H., Chandamuri, BR, Kharbanda, S. and Kalluri, R. (2001) Identification of the anti-angiogenic site within vascular basement-derived tumstatin. J Biol Chem, 276, pp. 15240-15248.
18. Marcinkiewicz, C., Calvete, JJ, Marcinkiewicz, MM, Raida, M., Lobb, RR, Senadhi, VK, Huang, Z. and Niewiarowski, S. (1999) EC3, a novel heterodimeric disintegrin from Echis carinatus venom, inhibits alpha4 and alpha5 integrins in an RGD-independent manner. J Biol Chem, 274, pp. 12468-12473.
19. Marcinkiewicz, C., Lobb, RR, Marcinkiewicz, MM, Daniel, JL, Smith, JB, Dangelmaier, C., Weinreb, PH, Beacham, DA and Niewiarowski, S. (2000) Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the a2b1 integrin. Biochemistry, 39, pp. 9859-9867.
20. Marcinkiewicz, C., Wainreb, PH, Calvete, JJ, Kisiel, DG, Mousa, SA, Tuszynski, GP and Lobb, RR (2003) Obtustatin, a potent inhibitor of a1b1 integrin in vitro and angiogenesis in vivo. Cancer Res, 63, pp. 2020-2023.
21. Muller, YA, Christinger, HW, Wells, JA, Cunningham, BC and de Vos, MA (1997) Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site. Proc Natl Acad Sci USA, 94, pp. 7192-7197.
22. Parsons-Wingerter, P., Lwai, B., Yang, MC, Elliot, KE, Milaninia, A., Redlitz, A., Clark, JI and Sage, H. (1998) A novel assay of angiogenesis in the quail chorioallantoic membrane: Stimulation by bFGF and inhibition by angiostatin according to fractal dimension and grid intersection. Microvasc Res, 55, pp. 201-214.
23. Quinn, TP, Peters, KG, deVries, C., Ferrara, N. and Williams, LT (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively express in vascular endothelium. Proc Natl Acad Sci USA, 90, pp. 7533-7537.
24. Semenza, GL (2000) Surviving ischemia: Adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest, 106, pp. 809-812.
25. Soker, S., Takashima, S., Miao, HQ, Neufeld, G. and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumoral cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92, pp. 735-745.
26. Sun, L., Tran, N., Tang, F., App, H., Hirth, P., McMahon, G. and Tang, C. (1998) Synthesis and biological evaluations of 3-substituted indolin-3-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J Med Chem, 41, pp. 2588-2603.
27. Suto, K., Yamazaki, Y., Morita, T. and Mizuno, H. (2005) Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: Insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1. J Biol Chem, 280, pp. 2126-2131.
28. Takahashi, H., Hattori, S., Iwamatsu, A., Takizawa, H. and Shibuya, M. (2004) A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1. J Biol Chem, 279, pp. 46304-46314.
29. Tokunaga, Y., Yamazaki, Y. and Morita, T. (2005) Specific distribution of VEGF-F in Viperinae snake venoms: Isolation and characterization of a VEGF-F from the venom of Daboia russelli siamensis. Arch Biochem Biophys, 439, pp. 241-247.
30. Yamazaki, Y. and Morita, T. (2006) Molecular and functional diversity of vascular endothelial growth factors. Mol Divers, 10, pp. 515-527.
31. Yamazaki, Y., Takani, K., Atoda, H. and Morita (2003) Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). J Biol Chem, 278, pp. 51985-51988.
32. de Vries, C., Escobedo, JA, Ueno, H., Houck, K., Ferrara, N. and Williams, LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, pp. 989-991.